Biogen Investment in biotechnology companies that are determined to be unconsolidated variable interest entities decreased by 2.8% to $48.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 150.8%, from $19.30M to $48.40M. Over 5 years (FY 2020 to FY 2025), Investment in biotechnology companies that are determined to be unconsolidated variable interest entities shows an upward trend with a 31.2% CAGR.
other_investment_in_biotechnology_companies_that_are_det_ee86a4| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.20M | $17.20M | $24.60M | $24.10M | $23.50M | $25.30M | $27.80M | $28.00M | $25.20M | $24.40M | $16.40M | $23.80M | $22.80M | $23.60M | $23.60M | $19.30M | $49.30M | $44.80M | $49.80M | $48.40M |
| QoQ Change | — | +13.2% | +43.0% | -2.0% | -2.5% | +7.7% | +9.9% | +0.7% | -10.0% | -3.2% | -32.8% | +45.1% | -4.2% | +3.5% | +0.0% | -18.2% | +155.4% | -9.1% | +11.2% | -2.8% |
| YoY Change | — | — | — | — | +54.6% | +47.1% | +13.0% | +16.2% | +7.2% | -3.6% | -41.0% | -15.0% | -9.5% | -3.3% | +43.9% | -18.9% | +116.2% | +89.8% | +111.0% | +150.8% |